FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Börse Stuttgart 03:45:00 2024-06-03 pm EDT | ||
| 5.31 EUR | -12.81% |
|
| Current month | -12.81% | ||
| 1 month | -41.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 5.31 | -12.81% |
| 24-05-31 | 6.09 | -16.69% |
| 24-05-30 | 7.31 | -10.74% |
| 24-05-29 | 8.19 | +8.48% |
| 24-05-28 | 7.55 | +0.27% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 03:45 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4G0K |
| ISIN | DE000JK4G0K3 |
| Date issued | 2024-03-22 |
| Strike | 262.4 $ |
| Maturity | Unlimited |
| Parity | 7.12 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 24.22 € |
|---|---|
| Lowest since issue | 4.95 € |
| Spread | 0.3 € |
| Spread % | 5.41% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
229.8
USD
Average target price
284.8
USD
Spread / Average Target
+23.93%
- Stock Market
- Certificates
- Certificat
